Get Well Soon
  • Innovation
  • About Us

300,000+ clinical trials. Find the right one.

1 active trial for SMF

Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF

The proposed study is an open-label, single-arm, Phase-Ib/II trial to assess the efficacy of oral drug combination ruxolitinib and pomalidomide in primary and secondary MF patients.

Start: August 2013
About Us
Innovation
Privacy
Terms
Copyright
Get Well Soon © Copyright 2022